NFRI Team and GeM Coordinating Center
Director of NFRI
David Miller, MD, PhD
Dr. Miller is board-certified in Medical Genetics and cares for patients with NF1 in the Multidisciplinary Neurofibromatosis Program at Boston Children’s Hospital where he is the Program Director. He is also currently leading an effort to update the clinical practice guidelines for children with Neurofibromatosis Type 1. Dr. Miller is also an expert in clinical genetic testing and serves as a Medical Director at Claritas Genomics (a subsidiary of Boston Children’s Hospital). Dr. Miller received his M.D. and Ph.D. degrees from Washington University School of Medicine in St. Louis, completed a residency in Pediatrics at Yale-New Haven Hospital, and residency/fellowship in medical genetics and clinical molecular genetics at Harvard Medical School. He is an Associate Professor of Pediatrics at Harvard Medical School, and an active contributor to the Human Genetics course at the Medical School. Dr. Miller’s experience as a clinician who orders genetic tests and provides results directly to patients, combined with expertise in developing and performing clinical laboratory diagnostic assays, provides him with a unique and valuable perspective at the interface of genomic technology and clinical care.
Education
WASHINGTON UNIVERSITY IN ST. LOUIS SCHOOL OF MEDICINE
MD, PhD, Biological Sciences, 1999
UNIVERSITY OF KENTUCKY
BS Biology; BA Chemistry, 1991
clinical research ASSISTANT
Aryani Pallerla
Aryani joined the NF1-TED Study as a Clinical Research Assistant in September 2023. She is interested in rare disease, neuroscience, and health equity research.
Education
UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL
B.S., Neuroscience, 2023
Co-op intern
Elena Lam
Elena joined the NF1-TED Study as a Co-op Intern in July 2024. She is an undergraduate student at Northeastern University studying Psychology and Public Health and is excited to expand her research experience with the NF1-TED Study team.